AI-powered digital twin platform that unifies fragmented enterprise data into a connected view, enabling real-time simulation, prediction, root cause analysis, and prescriptive insights for manufacturing operations.
This digital twin platform empowers manufacturers to make faster, more confident, and context-aware decisions by unifying structured and unstructured data across all enterprise systems. Built for industries such as life sciences, consumer goods, chemicals, food and beverage, and general manufacturing, the platform has delivered over $1 billion in economic value to global industry leaders. It enables risk identification, analysis, and mitigation through scenario-driven analysis and predictive modeling, helping organizations accelerate batch release cycles, reduce errors, and maintain regulatory compliance.
Key features:
The platform is commercially deployed and market-validated, with proven results across multiple manufacturing domains. The implementation approach begins with business problem definition and solution hypothesis, followed by data set determination, digital twin creation, AI model application, and simulation configuration. Solutions are deployed through the Mareana SaaS platform and made available to users with appropriate permissions, indicating a high level of commercial readiness.
Mareana is an AI-powered software company that provides a manufacturing intelligence platform specifically designed for the pharmaceutical, biotechnology, and industrial manufacturing industries. The platform integrates fragmented data from various systems, including legacy paper records, into a unified, GxP-compliant environment. By leveraging artificial intelligence, natural language processing, and predictive analytics, the company’s solutions enable manufacturers to digitize workflows, automate batch record reviews, and gain real-time insights. Their technology is built to handle 21 CFR Part 11 and EU Annex 11 requirements, effectively transforming complex, manual manufacturing processes into streamlined, data-driven operations. Key products in their portfolio include solutions for Continued Process Verification (CPV), Chemistry, Manufacturing, and Controls (CMC), and Value Stream Mapping (VSM).
These capabilities are critical for customers looking to accelerate batch release cycles, reduce errors, and ensure consistent regulatory compliance. By modernizing data management, Mareana helps manufacturers anticipate quality deviations, optimize production yields, and minimize overtime costs. The company has demonstrated significant financial impact for clients, including delivering substantial annual cost savings and yield improvements for global pharmaceutical firms. Recognized as a Cool Vendor in AI by Gartner, Mareana continues to support organizations in mitigating supply chain risks and achieving operational excellence, allowing scientific teams to focus on core drug development rather than manual data extraction.